Alliance Global has signed an agreement with Amgen to provide cancer mutation testing in certain countries in the Middle East and Africa. The partners have established a program to provide next-generation sequencing-based screening to identify colorectal cancer patients who have mutations in the RAS family of genes. They will utilize